Jun 2020 $2 M No. 5 Under $2 million 3
Cleveland Biolabs Inc.: Raise no. 5, Jun 2020 × Investors in this round 3 investors had bought by the notice of Jun 4, 2020: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $230,188
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrei S. Gudkov, Ph.D., D., Sci. · Executive Officer Christopher Zosh · Executive Officer Langdon S. Miller, MD · Executive Officer Alexander S. Andryushechkin · Director Anna S. Evdokimova · Director Daniil S. Talyanskiy · Director Ivan S. Fedyunin · Director Lea S. Verny · Director Randy S. Saluck · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in CA, IL, NY Remarks in the notice On fees: “In connection with a registered direct offering made concurrently with this placement, the issuer paid approximately $230,188 in placement agent fees and certain other compensation, as previously disclosed.”On the amounts: “The offering amount includes the aggregate purchase and exercise price of the warrants.”Signed by Christopher Zosh, Vice President of Finance. Source: SEC Form D, newest notice filed Jun 4, 2020. Read the notice at the SEC .
equity, options SEC Dec 2015 $1 M No. 4 Under $2 million 1
Cleveland Biolabs Inc.: Raise no. 4, Dec 2015 × Investors in this round 1 investor had bought by the notice of Dec 23, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrei J Gudkov · Executive Officer, Director C Neil Lyons · Executive Officer Langdon Neil Miller · Executive Officer Yakov J Kogan · Executive Officer, Director Anna Neil Evdokimova · Director Anthony J Principi · Director Ivan Neil Persiyanov · Director James J Antal · Director Konstantin Neil Gorshkov · Director Natalia Neil Khudyk · Director Natalia Neil Saraeva · Director Randy S Saluck · Director Richard S McGowan · Director Tatiana Neil Levina · Director Yulia Neil Lebedina · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by C. Neil Lyons, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 23, 2015. Read the notice at the SEC .
equity SEC Jul 2015 $25 M No. 3 $10 to $50 million 1
Cleveland Biolabs Inc.: Raise no. 3, Jul 2015 × Investors in this round 1 investor had bought by the notice of Jul 16, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $685,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrei J. Gudkov · Executive Officer, Director C. Neil Lyons · Executive Officer Yakov J. Kogan · Executive Officer, Director Anna Neil Evdokimova · Director Anthony J. Principi · Director Ivan Neil Persiyanov · Director James J. Antal · Director Konstantinie Neil Gorshkov · Director Natalia Neil Khudyk · Director Natalia Neil Saraeva · Director Randy S. Saluck · Director Richard S. McGowan · Director Tatiana Neil Levina · Director Yulia Neil Lebedina · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ladenburg & Thalmann & Co., Inc. (CRD 505) · New York, New York Sold in all US states Remarks in the notice On fees: “See the Company's Current Report on Form 8-K filed with the SEC on July 10, 2015.”Signed by C. Neil Lyons, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 16, 2015. Read the notice at the SEC .
equity SEC Jun 2014 $4 M No. 2 $2 to $10 million 3
Cleveland Biolabs Inc.: Raise no. 2, Jun 2014 × Investors in this round 3 investors had bought by the notice of Jul 3, 2014: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $30,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrei R. Gudkov · Executive Officer, Director C. Neil Lyons · Executive Officer Alexander R. Polinsky · Director Anthony J. Principi · Director Daniel F. Hoth · Director James R. Antal · Director Julia R. Brown · Director Randy S. Saluck · Director Richard S. McGowan · Director Yakov F. Kogan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C.WAINWRIGHT & CO., LLC (CRD 375) · New York, New York Sold in all US states Signed by Neil Lyons, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 3, 2014. Read the notice at the SEC .
equity, options SEC Mar 2010 $5 M No. 1 $2 to $10 million 9
Cleveland Biolabs Inc.: Raise no. 1, Mar 2010 × Investors in this round 9 investors had bought by the notice of Mar 5, 2010: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $350,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrei Gudkov · Director, Executive Officer Jack Marhofer · Executive Officer Michael Fonstein · Director, Executive Officer Yakov Kogan · Director, Executive Officer Bernard L. Kasten · Director Daniel Perez · Director James Antal · Director Paul DiCorleto · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Rodman & Renshaw, LLC (CRD 16415) · broker-dealer Rodman & Renshaw, LLC (CRD 16415) · New York, Ny Sold in no state named Remarks in the notice On fees: “Rodman and Renshaw received approximately $350,000 in cash and Warrants to purchase 123,077 shares of Cleveland Biolabs, Inc. common stock at an exercise price of $4.50 per share.”Signed by Michael Fonstein, President and CEO. Source: SEC Form D, newest notice filed Mar 5, 2010. Read the notice at the SEC .
equity, options SEC